ALIMERA SCIENCES, INC.
CIK 0001267602
Revenue (TTM)
$90.91M
+49.2% YoY
Q2 Aug 2024
Net Income (TTM)
−$20.95M
−11.2% YoY
Q2 Aug 2024
EPS Diluted (TTM)
−$2.21
+67.6% YoY
Q2 Aug 2024
Gross Margin
86.4%
Q2 Aug 2024
Operating Margin
-1.9%
Q2 Aug 2024
Net Margin
-23.0%
Q2 Aug 2024
Free Cash Flow (TTM)
−$11.75M
Q2 Aug 2024
Cash
$10.83M
Q2 Aug 2024
Total Debt
$38.66M
Q2 Aug 2024
Shares Outstanding
54.38M sh
Q2 Aug 2024